We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Precision Drug Delays Progression of BRCA-related Pancreatic Cancer

News   Jun 03, 2019 | Original story from Cancer Research UK

 
Precision Drug Delays Progression of BRCA-related Pancreatic Cancer in Clinical Trial
 
 
Advertisement
 

RELATED ARTICLES

FDA Approves Vericiguat for Use in Patients With Heart Failure

News

The US Food and Drug Administration (FDA) has approved the cardiovascular drug vericiguat. The drug is a once-daily oral treatment for patients with worsening chronic heart failure.

READ MORE

Biologists Unravel the Mechanism of Break-Induced Replication

News

Break-induced replication (BIR) is a way to solve those problems. In humans, it is employed chiefly to repair breaks in DNA that cannot be fixed otherwise. A new study seeks to tease out BIR’s high risk-reward arrangement by describing for the first time the beginning-to-end sequence in BIR.

READ MORE

Preventing Chemotherapy From Damaging the Heart

News

Researchers have discovered that the chemotherapy drug doxorubicin is able to enter heart cells by hitchhiking on a specific type of protein that functions as a transporter to move drugs from the blood into heart cells. By introducing another anti-cancer drug in advance of the chemotherapy, the team was able to block the transporter protein.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE